Search

Your search keyword '"Scalabrini A."' showing total 119 results

Search Constraints

Start Over You searched for: Author "Scalabrini A." Remove constraint Author: "Scalabrini A." Topic medicine.disease Remove constraint Topic: medicine.disease
119 results on '"Scalabrini A."'

Search Results

1. Traumatic effects beyond diagnosis: The impact of dissociation on the mind–body–brain system

2. Assessing Mental Representation as an Indicator of Self and Interpersonal Functioning in Psychotherapy Patients

3. All roads lead to the default-mode network—global source of DMN abnormalities in major depressive disorder

4. Use of CentriMag for refractory cardiogenic shock in a puerperal woman: case report

5. Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial

6. Time is of essence - Abnormal time perspectives mediate the impact of childhood trauma on depression severity

7. Antibody Therapies for Large B-Cell Lymphoma

8. Chemotherapy combinations for B-cell lymphoma and chemo-free approach in elderly patients: an update on best practice

9. Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial

10. Survival Analysis of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients in the Randomized Forte Trial

11. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target

12. Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma

13. Application of the Euro Clonality next-generation sequencing-based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial

14. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer

15. Beneath the surface: hyper-connectivity between caudate and salience regions in ADHD fMRI at rest

16. Dissociation as a disorder of integration – On the footsteps of Pierre Janet

17. IKKβ kinase promotes stemness, migration, and invasion in KRAS-driven lung adenocarcinoma cells

18. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

19. A Comprehensive and Systematic Analysis of Minimal Residual Disease (MRD) Monitoring in Follicular Lymphoma: Results from the Fondazione Italiana Linfomi (FIL) FOLL12 Trial

20. OAB-004: Carfilzomib-based induction/consolidation with or without autologous transplant and Lenalidomide (R) or Carfilzomib-Lenalidomide (KR) maintenance: efficacy in high-risk patients of the FORTE study

21. Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

22. Impact of Imaging FDG-PET/CT Minimal Residual Disease Assessment on Outcomes and Matching with Bone Marrow Techniques in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients: Results of the Phase II Randomized Forte Trial

23. Ixazomib-Based Induction Followed By Single-Agent Ixazomib Maintenance in Transplant Ineligible, Newly Diagnosed Multiple Myeloma Patients: Updated Results of the EMN10-Unito Trial

24. On-Demand Plerixafor with Cyclophosphamide and G-CSF for Hematopoietic Stem-Cell Mobilization in Multiple Myeloma Patients: Preliminary Results of a Prospective Observational Study (MOZOBL06877)

25. Safe Use of Carfilzomib in a Patient with Multiple Myeloma and Intermittent Type 1 Brugada ECG Pattern: A Case Report

26. Carfilzomib-based induction/consolidation with or without autologous transplant (ASCT) followed by lenalidomide (R) or carfilzomib-lenalidomide (KR) maintenance: Efficacy in high-risk patients

27. Post-Transplant Cyclophosphamide and Tacrolimus—Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors

28. The extent of dissociation in borderline personality disorder: A meta-analytic review

29. Personality and Personality Disorders

30. Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program

31. Prevalence of neuropathic component of pain in a cohort of patients admitted to an Internal Medicine Department for chronic pain

32. Post-Transplant Cyclophosphamide and Tacrolimus–Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors

33. Resveratrol Reverses the Impaired Vasodilation Observed in 2K-1C Hypertension through Endothelial Function Improvement

34. Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration

35. Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL)

36. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned

37. Patients with cirrhosis in the ED: early predictors of infection and mortality

38. Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study

39. Primary retroperitoneal mucinous cystadenoma - case report

40. Carfilzomib-Lenalidomide-Dexamethasone (KRd) Induction-Autologous Transplant (ASCT)-Krd Consolidation Vs KRd 12 Cycles Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Induction-ASCT-KCd Consolidation: Analysis of the Randomized Forte Trial in Newly Diagnosed Multiple Myeloma (NDMM)

41. Abstract B09: Exploring IKKβ as an antiangiogenic therapeutic target in KRAS-induced lung cancer

42. Lack of replication ofKIF1Bgene in an Italian primary progressive multiple sclerosis cohort

43. Novel exon 1 progranulin gene variant in Alzheimer’s disease

44. Gastric Bypass and Cardiac Autonomic Activity: Influence of Gender and Age

45. Incorrect Application Technique of Metered Dose Inhalers by Internal Medicine Residents: Impact of Exposure to a Practical Situation

46. SELPLG and SELP single-nucleotide polymorphisms in multiple sclerosis

47. P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis

48. A Large-Scale Study of Bone Marrow Involvement in Patients with Hodgkin's Lymphoma

49. GSK3β genetic variability in patients with Multiple Sclerosis

50. Phase II Trial of the Use of Gemcitabine and 5-Fluorouracil in the Treatment of Advanced Pancreatic and Biliary Tract Cancer

Catalog

Books, media, physical & digital resources